Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Antonio Nicolucci & Luca Leonardi. (2022) Compatibility of PiC Insupen Needles with a Broad Range of Pens for the Injection of Subcutaneously Administered Drugs for Diabetes. Medical Devices: Evidence and Research 15, pages 71-77.
Read now
Read now
Giorgia De Berardis, Marco Scardapane, Giuseppe Lucisano, Santina Abbruzzese, Antonio Carlo Bossi, Elisa Cipponeri, Paola D’Angelo, Lucia Fontana, Roberta Lancione, Giuseppe Marelli, Luigi Sciangula & Antonio Nicolucci. (2018) Efficacy, safety and acceptability of the new pen needle 34G × 3.5 mm: a crossover randomized non-inferiority trial; AGO 02 study. Current Medical Research and Opinion 34:9, pages 1699-1704.
Read now
Read now
Reema Mody, Michael Grabner, Maria Yu, Ralph Turner, Anita Y. M. Kwan, Whitney York & Laura Fernández Landó. (2018) Real-world effectiveness, adherence and persistence among patients with type 2 diabetes mellitus initiating dulaglutide treatment. Current Medical Research and Opinion 34:6, pages 995-1003.
Read now
Read now
Timothy S. Bailey & Jenine Y. Stone. (2017) A novel pen-based Bluetooth-enabled insulin delivery system with insulin dose tracking and advice. Expert Opinion on Drug Delivery 14:5, pages 697-703.
Read now
Read now
William H Polonsky & Robert R Henry. (2016) Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors. Patient Preference and Adherence 10, pages 1299-1307.
Read now
Read now
Margaret Tiktin, Selda Celik & Lori Berard. (2016) Understanding adherence to medications in type 2 diabetes care and clinical trials to overcome barriers: a narrative review. Current Medical Research and Opinion 32:2, pages 277-287.
Read now
Read now
Articles from other publishers (22)
F. Del Baldo, L. Colajanni, S. Corradini, P. Palagiano, A. Di Cunzolo, L. Perissinotto, I. Drudi, L. Horspool & F. Fracassi. (2022) Owner preference for insulin delivery device and glycaemic control in diabetic dogs. Journal of Small Animal Practice 64:4, pages 255-264.
Crossref
Crossref
Magaly Perez-Nieves, Rattan Juneja, Ludi Fan, Eric Meadows, Maureen J Lage & Elizabeth L Eby. (2021) Trends in U.S. Insulin Use and Glucose Monitoring for People with Diabetes: 2009-2018. Journal of Diabetes Science and Technology 16:6, pages 1428-1435.
Crossref
Crossref
Timothy T. Pham, Xiaoxue Chen, John Barron, Richard Hart, Jacob Abarca & Andrea DeVries. (2022) Effectiveness, safety and treatment adherence of biosimilar follow‐on insulin in diabetes management. Diabetes, Obesity and Metabolism 24:10, pages 1989-1997.
Crossref
Crossref
Tejaswi Kompala & Aaron B. Neinstein. (2021) Smart Insulin Pens: Advancing Digital Transformation and a Connected Diabetes Care Ecosystem. Journal of Diabetes Science and Technology 16:3, pages 596-604.
Crossref
Crossref
Małgorzata Masierek, Katarzyna Nabrdalik, Oliwia Janota, Hanna Kwiendacz, Maksymilian Macherski & Janusz Gumprecht. (2022) The Review of Insulin Pens—Past, Present, and Look to the Future. Frontiers in Endocrinology 13.
Crossref
Crossref
Robert Veasey, Carolin A. Ruf, Dmitri Bogatirsky, Jukka Westerbacka, Arnd Friedrichs, Mona Abdel-Tawab, Steffen Adler & Senthilnathan Mohanasundaram. (2021) A review of reusable insulin pens and features of TouStar—a new reusable pen with a dedicated cartridge. Diabetology & Metabolic Syndrome 13:1.
Crossref
Crossref
Shastri Motilal. (2020) Physician related barriers towards insulin therapy at primary care centres in Trinidad: a cross-sectional study. BMC Family Practice 21:1.
Crossref
Crossref
Hanxi ZhangJamie C BarnerLeticia R MoczygembaKaren L Rascati. (2020) Assessment of basal insulin adherence using 2 methodologies among Texas Medicaid enrollees with type 2 diabetes. Journal of Managed Care & Specialty Pharmacy 26:11, pages 1434-1444.
Crossref
Crossref
Arvind GuptaSanjeev PhatakY. Sadashiv RaoJayanthy Ramesh & Debmalya Sanyal. (2020) Consensus on Choice of Insulin Pen Devices in Routine Clinical Practice in India. Diabetes Technology & Therapeutics 22:10, pages 777-786.
Crossref
Crossref
Rebecca S. Holmes, Elizabeth Crabtree & Marian S. McDonagh. (2019) Comparative effectiveness and harms of long‐acting insulins for type 1 and type 2 diabetes: A systematic review and meta‐analysis. Diabetes, Obesity and Metabolism 21:4, pages 984-992.
Crossref
Crossref
Judith J. Stephenson, Jay P. Bae, Amit D. Raval & David M. Kern. (2018) Bridging the Gap Between Self-Reported and Claims-Derived Adherence Measures for Basal Insulin Among Patients with Type 2 Diabetes Mellitus. Advances in Therapy 36:1, pages 118-130.
Crossref
Crossref
Teresa H. Truong, Trang T. Nguyen, Becky L. Armor & Jamie R. Farley. (2017) Errors in the Administration Technique of Insulin Pen Devices: A Result of Insufficient Education. Diabetes Therapy 8:2, pages 221-226.
Crossref
Crossref
Wenhui Wei, Jenny Jiang, Youbei Lou, Sohini Ganguli & Mark S. Matusik. (2017) Benchmarking Insulin Treatment Persistence Among Patients with Type 2 Diabetes Across Different U.S. Payer Segments. Journal of Managed Care & Specialty Pharmacy 23:3, pages 278-290.
Crossref
Crossref
Samuel StolpeMichel A. KroesNeil WebbTami Wisniewski. (2016) A Systematic Review of Insulin Adherence Measures in Patients with Diabetes. Journal of Managed Care & Specialty Pharmacy 22:11, pages 1224-1246.
Crossref
Crossref
Ronan Roussel, Bernard Charbonnel, Mourad Behar, Julie Gourmelen, Corinne Emery & Bruno Detournay. (2016) Persistence with Insulin Therapy in Patients with Type 2 Diabetes in France: An Insurance Claims Study. Diabetes Therapy 7:3, pages 537-549.
Crossref
Crossref
Geralyn SpollettSteven V. EdelmanPatricia MehnerClaudia WalterAlfred Penfornis. (2016) Improvement of Insulin Injection Technique. The Diabetes Educator 42:4, pages 379-394.
Crossref
Crossref
Pieralessandro Lasalvia, Julián Esteban Barahona-Correa, Diana Marcela Romero-Alvernia, Sebastián Gil-Tamayo, Camilo Castañeda-Cardona, Juan Gabriel Bayona, Juan José Triana, Andrés Felipe Laserna, Miguel Mejía-Torres, Paula Restrepo-Jimenez, Juliana Jimenez-Zapata & Diego Rosselli. (2016) Pen Devices for Insulin Self-Administration Compared With Needle and Vial. Journal of Diabetes Science and Technology 10:4, pages 959-966.
Crossref
Crossref
Caitlin M. Moorman Spangler, Beth D. Greck & Jancy H. Killian. (2016) Analysis of a Delivery Device Conversion for Insulin Aspart: Potential Clinical Impact in Veterans. Clinical Diabetes 34:2, pages 92-96.
Crossref
Crossref
Philip Levin, Steve Zhou, Emily Durden, Amanda M. Farr, Jasvinder Gill & Wenhui Wei. (2016) Clinical and Economic Outcomes Associated With the Timing of Initiation of Basal Insulin in Patients With Type 2 Diabetes Mellitus Previously Treated With Oral Antidiabetes Drugs. Clinical Therapeutics 38:1, pages 110-121.
Crossref
Crossref
Grabner Michael, Peng Xiaomei, Caroline Geremakis & Jay Bae. (2015) Demographic and Clinical Profiles of Type 2 Diabetes Mellitus Patients Initiating Canagliflozin Versus DPP-4 Inhibitors in a Large U.S. Managed Care Population. Journal of Managed Care & Specialty Pharmacy 21:12, pages 1204-1212.
Crossref
Crossref
S. Lane Slabaugh, Jonathan R. Bouchard, Yong Li, Jean C. Baltz, Yunus A. Meah & D. Chad Moretz. (2015) Characteristics Relating to Adherence and Persistence to Basal Insulin Regimens Among Elderly Insulin-Naïve Patients with Type 2 Diabetes: Pre-Filled Pens versus Vials/Syringes. Advances in Therapy 32:12, pages 1206-1221.
Crossref
Crossref
Stacey A. Seggelke, R. Matthew Hawkins, Joanna Gibbs, Neda Rasouli, Cecilia C. Low Wang & Boris Draznin. (2014) Effect of Glargine Insulin Delivery Method (Pen Device Versus Vial/Syringe) on Glycemic Control and Patient Preferences in Patients with Type 1 and Type 2 Diabetes. Endocrine Practice 20:6, pages 536-539.
Crossref
Crossref